NRIX
Nurix Therapeutics Inc
25.40$
-0.2%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 108.2% | 144.7% | 373.1% | 20.4% | 28.0% | 245.7% | 406.3% | 22.5% | |
| -8.2% | -44.7% | 100.0% | 100.0% | 100.0% | -145.7% | -306.3% | 77.5% | |
| 108.2% | 144.7% | 373.1% | 391.4% | 477.6% | 245.7% | 406.3% | 366.9% | |
| 17.8% | 26.8% | 91.5% | 104.9% | 98.4% | 55.7% | 84.2% | 62.8% | |
| 17.8% | 26.8% | 464.7% | 496.3% | 576.0% | 55.7% | 84.2% | 417.7% | |
| -26.0% | -71.5% | -364.7% | -396.3% | -476.0% | -201.4% | -390.5% | -340.2% | |
| 2.2% | 2.5% | 19.0% | 23.2% | 37.1% | – | – | – | |
| -23.8% | -69.0% | -357.9% | -393.5% | -466.9% | -187.0% | -354.4% | -314.0% | |
| 1.4% | 0.8% | -115.2% | 0.4% | -37.1% | 17.5% | 0.5% | 0.9% | |
| -25.2% | -69.7% | -242.7% | -393.9% | -429.9% | -187.0% | -354.9% | -314.9% | |
| -18.0% | -63.9% | -352.4% | -375.8% | -448.0% | -179.0% | -339.7% | -291.5% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.